Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03922256 · ClinicalTrials.gov registry record · NA
Prospective, Observational Clinical Investigation of the Exos Reformable Brace
A NA study, sponsored by Foundation for Orthopaedic Research and Education.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03922256: Completed NA study, sponsored by Foundation for Orthopaedic Research and Education.
NCT03922256 is a NA study that has completed, run by Foundation for Orthopaedic Research and Education. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03922256, a NA study, has completed, sponsored by Foundation for Orthopaedic Research and Education.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a prospective observational single cohort trial quantifying time to radiographic union (primary endpoint) and convenience, satisfaction, pain and resource requirements (secondary) for patients with non-operatively treated distal radius fractures managed with a thermoformable Exos short-arm brace.
Primary Outcome
radiographic time to union
Interventions
- OTHER molded brace
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2020-01-30 |
| Phase | NA |
What the finished NCT03922256 record still lists
NCT03922256 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which molded brace is the first listed.
NCT03922256 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03922256 about?
NCT03922256 is a clinical study titled "Prospective, Observational Clinical Investigation of the Exos Reformable Brace". This is a prospective observational single cohort trial quantifying time to radiographic union (primary endpoint) and convenience, satisfaction, pain and resource requirements (secondary) for patients with non-operatively treated distal radius fractures managed with a thermoformable Exos short-arm b...
What is the current status of trial NCT03922256?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-08-01. Estimated completion is 2020-01-30.
What interventions are being tested in trial NCT03922256?
The interventions under investigation include: molded brace (OTHER).
Who is sponsoring clinical trial NCT03922256?
This trial is sponsored by Foundation for Orthopaedic Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03922256's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI